These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33640144)

  • 21. Effectiveness of Enterovirus 71 inactivated vaccines against hand, foot, and mouth disease: A test-negative case-control study.
    Zhang Y; Cui J; Liu F; Song Y; Wang Q; Liu Y; Zhang Y; Li Z; Chang Z
    Hum Vaccin Immunother; 2024 Dec; 20(1):2330163. PubMed ID: 38544389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection.
    Duan X; Zhang L; Ding L; Zhang C; Chen Z; Cheng Y; Wang X; Peng H; Tang X; Ren X; Liao J; Yang S; Zhu Y; Luo W; Zeng Y; Yuan P; Long L
    Vaccine; 2024 Apr; 42(9):2317-2325. PubMed ID: 38433065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enterovirus A71 2A-S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines.
    Zhang P; Zou W; Xiong R; Wu Y; Fan C; Peng Y
    J Med Virol; 2024 Aug; 96(8):e29838. PubMed ID: 39081166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development.
    Yee PTI; Laa Poh C
    Virology; 2017 Jun; 506():121-129. PubMed ID: 28384566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys.
    Yang T; Xie T; Song X; Shen D; Li H; Yue L; Jiang Q; Zhu F; Meng H; Long R; Yang R; Luo F; Xie Z
    Hum Vaccin Immunother; 2020 Jul; 16(7):1586-1594. PubMed ID: 32159429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
    Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice.
    Tee HK; Tan CW; Yogarajah T; Lee MHP; Chai HJ; Hanapi NA; Yusof SR; Ong KC; Lee VS; Sam IC; Chan YF
    PLoS Pathog; 2019 Nov; 15(11):e1007863. PubMed ID: 31730673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates.
    Lim PY; Hickey AC; Jamiluddin MF; Hamid S; Kramer J; Santos R; Bossart KN; Cardosa MJ
    Vaccine; 2015 Nov; 33(44):6017-24. PubMed ID: 26271825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response.
    Diaz-San Segundo F; Medina GN; Ramirez-Medina E; Velazquez-Salinas L; Koster M; Grubman MJ; de los Santos T
    J Virol; 2016 Feb; 90(3):1298-310. PubMed ID: 26581977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
    Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
    BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An enterovirus A71 virus-like particle with replaced loops confers partial cross-protection in mice.
    Liu X; Zhu H; Wang M; Zhang N; Wang J; Tan W; Wu G; Yu P; Liu H; Liu Q
    Virus Res; 2023 Nov; 337():199235. PubMed ID: 37788720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of difference between EV-A71 virus epidemic strain and "vaccine strain" on neutralizing antibody titer.
    Ding Y; Han Z
    Hum Vaccin Immunother; 2022 Nov; 18(6):2121565. PubMed ID: 36112355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
    Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C
    Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan.
    Huang KA; Huang PN; Huang YC; Yang SL; Tsao KC; Chiu CH; Shih SR; Lin TY
    PLoS Pathog; 2020 Sep; 16(9):e1008857. PubMed ID: 32936838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of significant molecular determinants of virulence of Enterovirus 71 sub-genotype B4 in Rhabdomyosarcoma cells.
    Yee PTI; Mohamed RAH; Ong SK; Tan KO; Poh CL
    Virus Res; 2017 Jun; 238():243-252. PubMed ID: 28705680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71.
    Tan XH; Chong WL; Lee VS; Abdullah S; Jasni K; Suarni SQ; Perera D; Sam IC; Chan YF
    Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
    Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.
    Wang X; An Z; Huo D; Jia L; Li J; Yang Y; Liang Z; Wang Q; Wang H
    Hum Vaccin Immunother; 2019; 15(5):1183-1190. PubMed ID: 30779680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antivirals and vaccines for Enterovirus A71.
    Lin JY; Kung YA; Shih SR
    J Biomed Sci; 2019 Sep; 26(1):65. PubMed ID: 31481071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis on post-marketing effectiveness and immunogenicity of enterovirus-A71 vaccine].
    Hua RJ; Huang J; Zhang XJ; Shen Q; Cai MY; Yuan F; Zhang Y; Cui PF; Li Y; Shi HY; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Sep; 41(9):1518-1521. PubMed ID: 33076610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.